Physician profile
Leonard Behr
NPI 1255384731
$1,303.12
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,085 · 2020: $218.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $447.43 | 2019-2020 | |
| Amarin Pharma, INC. | $264.05 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $195.75 | 2019 | |
| Astellas Pharma US INC | $110.00 | 2019-2020 | |
| Pfizer INC. | $60.79 | 2019 | |
| Merck Sharp & Dohme LLC | $36.28 | 2019-2020 | |
| Allergan, INC. | $35.55 | 2019 | |
| Sanofi Pasteur INC. | $24.70 | 2019-2020 | |
| Metuchen Pharmaceuticals | $21.24 | 2019 | |
| Sanofi-Aventis U.S. LLC | $19.92 | 2019 | |
| Novo Nordisk INC | $18.44 | 2019 | |
| Abbvie INC. | $15.53 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.32 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.52 | 2020 | |
| Ironwood Pharmaceuticals, INC | $11.81 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $11.79 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonard Behr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.